HEALWELL AI

Our mission is to improve healthcare and save lives through early identification and detection of disease.

Recent News

HEALWELL Gives Notice of Imminent Exercise of Call Option by WELL Health

Toronto, Ontario--(Newsfile Corp. - March 31, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, announced today that it understands WELL Health Technologies Corp. ("WELL") intends to exercise its right to acquire 30,800,000 Class A Subordinate Voting Shares ("SVS") and 30,800,000 Class B Multiple Voting Shares ("MVS") of the Company from certain of its existing shareholders (the "Call...

2025-03-31 7:00 AM EDT

CORRECTION FROM SOURCE: HEALWELL Reports Record Revenue with 433% Growth in 2024, and Anticipates Closing of Transformational Orion Health Acquisition on April 1, 2025

Correction from Source: In the previously issued press release this morning, the full year 2024 Adjusted EBITDA loss was inadvertently reported as $1 million. The correct Adjusted EBITDA(1) loss is $16 million. The press release is re-issued below in its entirety with this one correction. HEALWELL achieved record annual revenue from continuing operations of approximately $39 million in fiscal 2024, an increase of 433% compared to fiscal 2023. HEALWELL achieved record quarterly revenue from...

2025-03-26 12:09 PM EDT

HEALWELL Reports Record Revenue with 433% Growth in 2024, and Anticipates Closing of Transformational Orion Health Acquisition on April 1, 2025

HEALWELL achieved record annual revenue from continuing operations of approximately $39 million in fiscal 2024, an increase of 433% compared to fiscal 2023. HEALWELL achieved record quarterly revenue from continuing operations of $15.2 million in Q4-2024, 692% higher than the $1.9 million generated in Q4-2023 and 11% higher than the $13.7 million generated in Q3-2024. On December 16, 2024, HEALWELL announced the acquisition of Orion Health Holdings Limited ("Orion Health", or "Orion"), a...

2025-03-26 9:46 AM EDT

HEALWELL AI to Announce Fourth Quarter and Year End 2024 Financial Results on March 26, 2025

Toronto, Ontario--(Newsfile Corp. - March 20, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the Company will release its Fiscal Fourth Quarter and Year End 2024 financial results for the period ended December 31, 2024, on Wednesday, March 26, 2025. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00...

2025-03-20 4:15 PM EDT

HEALWELL Signs $50M Credit Agreement Led by Scotiabank and RBC to Support Orion Acquisition, and Commences Pre-Closing Procedures

HEALWELL has signed a $50 million credit agreement, contingent on and in support of its acquisition of Orion Health, with credit to be provided by a syndicate of Schedule I Canadian Banks, including The Bank of Nova Scotia as Sole Bookrunner, Admin Agent, and Co-Lead Arranger, and Royal Bank of Canada as Co-lead Arranger. The credit agreement also provides for an additional uncommitted future accordion feature of up to $25 million. Between this credit agreement and the capital raised through...

2025-03-10 3:15 AM EDT

HEALWELL to Participate in Upcoming Scotiabank TMT and ROTH Investor Conferences

Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL AI, will be participating in the following upcoming investor conferences: 28th Annual Scotiabank TMT Conference Date: March 4-5, 2025 Location: Scotiabank Conference Centre, Toronto Presentation Time: March 5, 12:25 PM...

2025-02-27 3:15 AM EST

HEALWELL's VeroSource Unveils Digital Twin Technology to Bring Real-Time Intelligence to Healthcare Management

VeroSource to support cutting edge Digital Twin technology on its VS Data-as-a-Service Platform, delivering real-time insights and advanced data visualization to optimize healthcare operations. A Digital Twin is a virtual model of a healthcare system or facility that provides real-time insights for better decision-making. By simulating operations without disruption, this technology allows healthcare managers to optimize efficiency, reduce costs, and enhance patient care. Key Features of...

2025-02-26 3:15 AM EST

HEALWELL's Khure Health Provides Update Highlighting Significant Acceleration in User and Life Sciences Partner Adoption of Disease Detection AI Powered Co-Pilots and Strong Physician NPS Scores

In Q4-2024, HEALWELL's subsidiary, Khure Health ("Khure") helped physicians identify over 43,000 high-risk patients with its AI-Powered Physician Co-Pilots, across 8 clinical specialities harnessing 132 disease specific algorithms. This figure reflected a quarter over quarter sequential growth of 22% as compared to Q3-2024 and year-over-year growth of 500% as compared to Q4-2023. HEALWELL has executed 4 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q4-2024...

2025-02-24 3:15 AM EST

HEALWELL's Pentavere Publishes Study in the Journal of Liquid Biopsy; Validating DARWEN(TM) AI as a Leading Artificial Intelligence Clinical Decision Support Tool in Oncology

The use of the DARWEN™ AI platform achieved time savings representing a 100-fold improvement as compared to traditional manual processes(1), demonstrating the opportunity to advance care and improve patient outcomes by leveraging cutting edge AI technology in clinical care. This study was conducted in collaboration with Princess Margaret Cancer Centre and is one of the world's first peer-reviewed studies to use an artificial intelligence platform to demonstrate the value of liquid biopsies in...

2025-02-13 3:15 AM EST

HEALWELL Receives Regulatory Approval from Overseas Investment Office of New Zealand to Acquire Orion Health

HEALWELL receives consent from the Overseas Investment Office of New Zealand (the "OIO") for HEALWELL to acquire all of the shares (the "Orion Shares") of Orion Health Holdings Limited ("Orion Health"), as contemplated in the previously disclosed share purchase agreement dated December 16, 2024. Orion Health is a leader in global healthcare technology, with over 70 customers worldwide in 11 countries and approximately 400 team members. Orion Health generates revenues via subscription license...

2025-02-10 3:15 AM EST

HEALWELL Provides Corporate Update Including Strategic Cost Optimization Initiative to Streamline Operations and Pursue M&A Efficiencies

HEALWELL expects to achieve at least $3.0 million in annual cost savings through a strategic cost optimization initiative. HEALWELL is focussed on aligning its operations ahead of the anticipated closing of its previously announced acquisition of New Zealand based Orion Health ("Orion") to optimize synergies and streamline operations between the two companies. HEALWELL also disclosed that it expects to be favourably positioned in the event the U.S. tariffs against Canada were to expand beyond...

2025-02-03 3:15 AM EST

HEALWELL AI Closes the $30M Convertible Debt Tranche of its Upsized Bought Deal Financing

Toronto, Ontario--(Newsfile Corp. - January 28, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that it has completed the second tranche (the "Second Closing") of its previously anno

2025-01-28 2:35 PM EST

HEALWELL AI Closes the $25.5M Equity Tranche of Its Upsized Bought Deal Financing

Toronto, Ontario--(Newsfile Corp. - January 21, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that it has completed the first

2025-01-21 11:41 AM EST

HEALWELL AI Receives Written Shareholder Approval for Pending Acquisition of Orion Health and Related Financing

Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that it has obtained sharehold

2025-01-14 3:15 AM EST

HEALWELL Acquires Control of Mutuo Health Solutions to Build Next Generation of AI-Powered Physician Co-Pilots

HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Mutuo Health's AutoScribe platform is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time using natural language processing and machine learning technology. AutoScribe's speech recognition capabilities,...

2024-12-03 3:15 AM EST

HEALWELL's VeroSource Solutions Provides Corporate Update Demonstrating Rapid Growth and Expansion Across Canadian Public Sector Clients

More than 600,000 New Brunswick residents are now eligible to generate a Patient Summary on the VeroSource-built MyHealthNB digital front door. This year, MyHealthNB averaged over 35,000 unique monthly users in New Brunswick, reflecting 100% growth compared to 2023. The VeroSource-managed Saskatchewan Health Authority website was accessed by patients and providers over 1.3 million times in 2024, representing a 50% increase in traffic from the previous year. In addition to its successful...

2024-11-27 3:15 AM EST

HEALWELL AI Appoints Beatrice York, Dr. Marcel Reichart, and Reeva Misra to Strategic Advisory Board

Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased

2024-11-19 3:15 AM EST

HEALWELL Reports Record Revenue and Increased Customer Activity from Pharmaceutical Partners in Q3-2024

HEALWELL achieved record quarterly revenue from continuing operations of $13.7 million in Q3-2024, 738% higher than the $1.6 million generated in Q3-2023 and 153% higher than the $5.4 million generated in Q2-2024. Quarterly revenues were driven by HEALWELL completing the acquisitions of BioPharma Services Inc. and VeroSource Solutions Inc. during Q3-2024. Management maintains a positive outlook and based on current M&A pipeline continues to expect to make further M&A announcements by year-end...

2024-11-12 5:00 AM EST

HEALWELL's Pentavere Receives Prestigious Prix Galien USA 2024 Award for Best Digital Health Startup for Its Contributions in AI for Life Sciences Industry

The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical, medical, and technology achievements that improve the human condition and is considered the industry's equivalent of the Nobel Prize. Pentavere's DARWEN™ AI platform was awarded for its proven contribution in making healthcare more accessible and personalized for patients and for using various forms of AI including generative AI to help identify patients and detect...

2024-11-12 3:15 AM EST

HEALWELL Provides Corporate Update on Accelerating Commercialization and Expansion of Pharmaceutical Partnerships by Leveraging Its Best-in-Class Patient Identification Capabilities

HEALWELL's AI and data science subsidiaries have executed 5 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q3-2024; bringing the total number of MSAs with life sciences partners to 27, which includes 6 of the top 10 pharmaceutical companies in the world. HEALWELL's AI and data science subsidiaries generated patient identification revenue from 23 of these pharmaceutical partners in Q3-2024. HEALWELL subsidiary, Khure Health, has executed an MSA for patient...

2024-11-05 3:15 AM EST

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us